| Course | HLTH 8475 Advanced Program Implementation and Evaluation |
|---|---|
| Week | Week 10 |
| Paper type | Counterargument brief |
| Length | About 680 words, 5 pages |
| Format | APA 7 student paper |
| School | Walden University |
| Program | PhD in Public Health |
| Updated | October 2026 |
Free sample paper for HLTH 8475 Week 10
Counterargument Brief: The Strongest Case That the Rural Pharmacy PrEP Program Did Not Work, and Which Parts of That Case the Evidence Answers and Which It Leaves Standing
Student Name
Walden University
HLTH 8475: Advanced Program Implementation and Evaluation
Instructor Name
Month Day, Year
Counterargument Brief: The Strongest Case That the Rural Pharmacy PrEP Program Did Not Work, and Which Parts of That Case the Evidence Answers and Which It Leaves Standing
The Case Against the Program
A skeptical county director could make the following argument, and this brief makes it as strongly as possible before testing it.
The program missed its own primary clinical target. It set a persistence level of 60% before launch, and only 58% of clients who had been in the program six months were persistent. It cannot claim credit for the fall in district HIV diagnoses, since that fall matches a return from an unusual cluster year to the earlier average, exactly the pattern Campbell (1969) warned produces false credit for reforms. Its reach was limited: 118 people in a year, a small share of those in the district who might benefit, and one of its three referral sources stopped working for most of the year without anyone noticing. Two of its four pharmacies performed poorly. Its pharmacists at the smaller sites found the workload unsustainable, and one left. Clients in the smallest town avoided their local pharmacy for privacy, which undercuts the program's central idea of care close to home. And all of its evidence is observational, from one district, with small numbers at each site.
What the Evidence Answers
Some of this case does not survive the evidence.
The persistence shortfall is real, but it is concentrated at the two pharmacies where delivery broke down. The two sites that delivered the program as designed exceeded the target at 68% and 63%. That pattern points to a type III error at the weaker sites: evaluating a program as if it had been delivered when, in important respects, it had not. Dobson and Cook (1980) described type III error as judging a program's effects without confirming that the program was implemented; concluding that the program fails when two sites never fully delivered it would repeat that mistake.
The safety evidence is strong for what it covers. Not a single client became infected while taking PrEP, and nearly all refills followed a negative test on file.
The referral failure was a fixable implementation problem, found by the process evaluation, not evidence that the program design is unworkable.
What the Evidence Leaves Standing
Other parts of the case remain.
The program cannot show any effect on district-wide HIV diagnoses. The decline is fully consistent with regression to the mean and with the cluster response's other measures. The brief concedes this completely: the program should not claim that it reduced HIV in the district.
The privacy problem in small towns is a design issue, not just a delivery lapse. A pharmacy-based model assumes that care close to home is better, and some clients in very small towns disagree. The evaluation cannot answer this with better implementation; it needs a design change, such as telehealth follow-up with a pharmacist elsewhere.
Workload at small pharmacies is also unresolved. If the program's sustainability depends on two trained pharmacists per site, the smallest pharmacies may not be able to support it, and the program may need to concentrate in fewer, larger sites.
And the evidence is observational. Without a comparison group, the program cannot show that persistence at its strongest sites is higher than it would have been through other routes to PrEP.
Where This Leaves the Program
The program did not fail. It worked where delivered as designed, and it has two weaknesses that better implementation alone will not fix: small-town privacy and small-pharmacy workload. Proctor et al. (2011) separated implementation outcomes from clinical ones so that evaluators can tell an undelivered program apart from an ineffective one. The final report should claim the first finding, concede the second set of problems and recommend changes to the design as well as to delivery.
Pointing at Earlier Work
The brief also shows a weakness in the measurement plan itself: it did not track referrals by source, which let the referral failure go unnoticed for months. The final report should say so.
References
Campbell, D. T. (1969). Reforms as experiments. American Psychologist, 24(4), 409-429. https://doi.org/10.1037/h0027982
Dobson, D., & Cook, T. J. (1980). Avoiding type III error in program evaluation. Evaluation and Program Planning, 3(4), 269-276. https://doi.org/10.1016/0149-7189(80)90042-7
Proctor, E., Silmere, H., Raghavan, R., Hovmand, P., Aarons, G., Bunger, A., Griffey, R., & Hensley, M. (2011). Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda. Administration and Policy in Mental Health and Mental Health Services Research, 38(2), 65-76. https://doi.org/10.1007/s10488-010-0319-7
The Walden HLTH 8475 Week 10 instructions
The Week 10 brief asks students to build the strongest case that their program did not work and then sort it into parts the evidence answers and parts it leaves standing. The case against should be stated in full before any answer. Faculty expect accurate use of evaluation concepts such as type III error and regression to the mean, and honest concessions where the case holds. The brief should also point to weaknesses in earlier assignments where they contributed. The conclusion should say what the final report must carry forward, so the concessions shape the recommendation rather than disappear. Faculty also value a brief that separates failures of delivery from weaknesses in the design itself.
How this HLTH 8475 Week 10 example is built
The opening states a skeptical director's case in full: the missed target, regression in district diagnoses, limited reach, a failed referral source, weak sites, workload and privacy, and observational evidence, citing Campbell. A section on what the evidence answers shows the shortfall concentrated at weak sites and applies Dobson and Cook's type III error, notes the safety record and treats the referral failure as fixable. A section on what remains concedes the population claim, small-town privacy, small-pharmacy workload and the lack of a comparison group. A section concludes that the program worked where delivered as designed and has two design weaknesses, citing Proctor and colleagues. A short section names a gap in the measurement plan.
Where the marks sit in the HLTH 8475 Week 10 rubric
Faculty weigh two things in this brief: how strong the case against is, and how honestly it is sorted. A brief that states weak objections, or answers each one immediately, earns limited credit. The rubric rewards a case stated as a skeptic would state it, accurate use of evaluation concepts and concessions where the evidence does not answer the objection. Faculty value distinguishing delivery failures from design weaknesses, since they call for different remedies. Pointing to gaps in the author's own earlier plans shows integrity. A conclusion that names what the final report must concede connects the brief to the course's last assignment. Strong briefs make the skeptic's case in the skeptic's voice.
HLTH 8475 Week 10 help: mistakes that cost marks
Students arguing against their own programs often soften the case or answer every point. Others conclude that the program failed because they found objections. To write a stronger brief, imagine the most skeptical decision maker and write their argument in full. Then sort each point: does your evidence answer it, partly answer it or leave it standing? Use concepts such as type III error where they fit. Concede what stands. Point to weaknesses in your own earlier plans. Say what the final report must include. Separate delivery failures from design weaknesses, since they call for different fixes. A counterargument brief against your own program can be drafted for you to compare.
Get a HLTH 8475 Week 10 example written to your instructions
Share the Week 10 prompt and rubric with the outcome analysis the objections should target. The brief is drafted against those results and returns inside 24-48h, the first at no charge. It argues against the program in earnest, so expect concessions you may keep, cut or answer in the final report.
More HLTH 8475 papers and PhD in Public Health samples
- HLTH 8475 Week 1: Clearances Framing Post
- HLTH 8475 Week 2: Program Adaptation Post
- HLTH 8475 Week 3: Implementation Logic Model
- HLTH 8475 Week 4: Staged Implementation Plan
- HLTH 8475 Week 5: Pre-Set Measurement Plan
- HLTH 8475 Week 6: Reach Measure Peer Critique
- HLTH 8475 Week 7: Six-Month Process Evaluation
- HLTH 8475 Week 8: Rival Explanations Post
- HLTH 8475 Week 9: Site-Level Outcome Analysis
- HLTH 8475 Week 11: Utilization-Focused Evaluation Report
- HLTH 8402 Week 10: Clinic Stop Counterargument
- HLTH 8392 Week 10: Consolidation Communication Plan
- HLTH 8317 Week 10: Categorical Funding Brief
- HLTH 8247 Week 10: Replication Appraisal
HLTH 8475 Week 10 questions, answered
Should the brief conclude that the program failed?
It concludes what the evidence allows. The sample argues the case against as strongly as it can, then marks each objection by status. Usually at least one stands, and the brief admits it plainly. Declaring failure outright would be as unearned as declaring success, and the rubric for this week tends to reward the honest middle more than either extreme.
Where can I find a free HLTH 8475 Week 10 sample paper?
The complete Week 10 counterargument brief is on this page, building the case that a rural pharmacy PrEP program failed and sorting which parts the evidence answers, with three references.
What is a type III error in this context?
Judging a program's effects without confirming that it was delivered as designed; concluding the pharmacy PrEP program fails because of results at two sites that never fully implemented it would be one.
Which earlier assignment does the brief criticize?
The measurement plan, which did not track referrals by source, so the failure of one referral source went unnoticed for months until the process evaluation matched records.
Does the brief conclude the program failed?
No. It concludes the program worked where it was delivered as designed and has two design weaknesses, small-town privacy and small-pharmacy workload, that the final report must address.